Sign in to continue:

Wednesday, February 11th, 2026

Author: minichart

Hongxing Coldchain (Hunan) Co., Ltd. Global Offering: Key Dates, Application Guide & IPO Details for 2026 2

Hongxing Coldchain (Hunan) Co., Ltd. – IPO Analysis and Investor Overview Hongxing Coldchain (Hunan) Co., Ltd. Date of Prospectus: December 31, 2025 Deep Dive: Hongxing Coldchain’s HKEX IPO Targets Growth in China’s Cold Chain...

GigaDevice Semiconductor Inc. (兆易创新) Global Offering: Leading Fabless IC Design in Specialty Memory, MCU, Analog & Sensor Chips for AI, Automotive, and IoT

GigaDevice Semiconductor Inc. 2025 IPO Analysis: Investor’s Guide to Offer Structure, Financials, and Market Outlook Company name: GigaDevice Semiconductor Inc. Date of prospectus: December 31, 2025 GigaDevice Semiconductor Inc. Launches Landmark IPO: Deep Dive...

OmniVision Integrated Circuits Group, Inc. Global Offering 2026: Hong Kong IPO Details, Application Process & Key Dates 2 3 7

OmniVision Integrated Circuits Group, Inc. Hong Kong IPO Analysis and Investment Outlook Company Name: OmniVision Integrated Circuits Group, Inc. Date of Prospectus: December 31, 2025 OmniVision Integrated Circuits Group, Inc. Launches Landmark Hong Kong...

GigaDevice Semiconductor Inc. Global Offering: Key Dates, Application Guide & Hong Kong IPO Details 2026

GigaDevice Semiconductor Inc. Hong Kong IPO: Key Analysis and Investor Guide GigaDevice Semiconductor Inc. Date of Prospectus: December 31, 2025 GigaDevice Semiconductor Inc. Launches Landmark Hong Kong IPO: Critical Insights for Investors GigaDevice Semiconductor...

Sichuan Biokin Pharmaceutical Hong Kong IPO: Innovative Oncology Drugs, Global Expansion & Key Financials (2025)

Baili Pharmaceutical IPO Analysis: Key Details, Financials, Risks, and Outlook Baili Pharmaceutical Co., Ltd. Date of Prospectus: November 7, 2025 Baili Pharmaceutical Hong Kong IPO: Strategic Growth in Oncology, Financials, and Investor Outlook IPO...

Sichuan Biokin Pharmaceutical Global Offering 2025: Hong Kong IPO Details, Application Process & Key Dates

Sichuan Biokin Pharmaceutical Co., Ltd. IPO Analysis Company Name: Sichuan Biokin Pharmaceutical Co., Ltd. Date of Prospectus: November 7, 2025 Sichuan Biokin Pharmaceutical IPO: In-Depth Analysis, Offer Details, and Investor Insights Sichuan Biokin Pharmaceutical...

APAC Realty Ltd Technical Buy Signal: Bullish Breakout and Target Prices for 2026 2

Broker Name: CGS International Date of Report: January 9, 2026 Excerpt from CGS International report. Report Summary APAC Realty Ltd is highlighted as a technical buy after the end of a bullish corrective structure,...

DBS Singapore Stock Picks Update: Reduce City Development, Add Seatrium, APAC Realty Favored Over PropNex for Yield 12

DBS, June 2024 Excerpt from DBS report. Report Summary DBS recommends reducing exposure to City Development after a 23% share price rise, while adding Seatrium to its equity picks on the back of strong...

Maybank Singapore Daily 2026: Top Equity Ideas, Market News & Stock Ratings Explained

Maybank Research Pte Ltd Date of report: 9 January 2026 Excerpt from Maybank Research Pte Ltd report. Report Summary Sea Ltd upgraded to BUY after a major correction, with Shopee investments strengthening its ASEAN...

Coliwoo Holdings: Leading Singapore’s Co-Living Market with Asset-Light Expansion and Strong Growth Prospects

Broker Name: Maybank Research Pte Ltd Date of Report: January 9, 2026 Excerpt from Maybank Research Pte Ltd report. Report Summary: Coliwoo Holdings is one of Singapore’s largest co-living operators, with about 2,933 rooms...